Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
212.00    1.50 (0.71%)
Bid:
211.00
Ask:
213.00
Spread: 2.00 (0.948%)
Market Cap: £144.65m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Directorate Change

1 Jul 2024 07:00

RNS Number : 5464U
Helios Underwriting Plc
01 July 2024
 

Helios Underwriting plc

("Helios" or the "Company")

1st July 2024

Appointment of Non-Executive Director

Helios Underwriting ('Helios' or the 'Company'), the only publicly traded investment company offering instant access to a diverse portfolio at Lloyd's of London, the world's largest insurance market, is pleased to announce the appointment to the Board of John Chambers as an Independent Non-Executive Director. John's appointment took effect after the Company's Annual General Meeting on 28th June 2024.

 

John previously worked at AEGIS London, where he was Director of Underwriting, and helped build the business from a fledgling syndicate into one of the largest and most profitable in the London Market. He brings considerable experience across all aspects of running a regulated insurer, from business planning through underwriting management to risk management, as well as financial and regulatory reporting.

 

Michael Wade, Executive Chairman of Helios, commented: "I am pleased to announce that John will be joining our Board as an Independent Non-Executive Director. He brings with him considerable experience of running a highly successful Lloyd's business. I'm looking forward to working closely with him as we seek to capitalise on excellent market conditions and maintain our status as the pre-eminent provider of private capital to the Lloyd's market."

 

John Chambers, added: "The Lloyd's market is highly regulated, financially robust, and uniquely positioned. Market conditions have never been better, with increased underwriting discipline and sustainable price increases expected to last for years. I'm excited to add my knowledge of the Lloyd's market to Helios' already highly experienced Board, as we help drive forward the strategy and actively manage a balanced portfolio of Lloyd's syndicate participations."

 

 

AIM Rule 17

The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies:

 

John Edmond Chambers, aged 59, owns or has an interest in 560,000 ordinary shares in the Company. John Chambers' current and previous directorships are as follows:

 

Current Partnerships / Directorships

Previous Partnerships / Directorships (last 5 years)

Dora Holdings Jersey Limited

Fairburn Bistromathics Limited

Fairburn Capital Limited

Fairburn Continuation Limited

TT Club Mutual Insurance Ltd

Through Transport Mutual Insurance Association Limited

 

AEGIS Managing Agency Limited

St. Thomas More Catholic Primary School

 

Save as disclosed above, there are no further disclosures to be made in accordance with Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

For further information, please contact:

Helios Underwriting plc

Michael Wade - Chairman

Arthur Manners - Chief Financial Officer +44 (0)203 965 6441

Deutsche Numis (Nomad and Broker)

 Giles Rolls / Charles Farquhar

+44 (0)20 7260 1000

 

FTI Consulting

 Ed Berry / Nathan Hambrook-Skinner

+44 (0)7703 330 199 / +44 (0)7977 817 092

 About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £507m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKZGGNKMRGDZG
Date   Source Headline
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings
2nd Oct 20237:00 amRNSTotal Voting Rights
28th Sep 20237:00 amRNSHalf Year Results
11th Sep 202311:46 amRNSTransaction in Own Shares
8th Sep 202310:23 amRNSTransaction in Own Shares
8th Sep 20237:00 amRNSTransaction in Own Shares
5th Sep 20233:27 pmRNSTransaction in Own Shares
4th Sep 20233:36 pmRNSTransaction in Own Shares
1st Sep 202311:06 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.